Logo

About Bentham Science Publishers


Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, and EMBASE.

Read More

Meet the Executive Guest Editors Join as Executive Guest Editor


  • Generic placeholder image

    M. Lin
    Taizhou People’s Hospital Jiangsu China

    Executive Guest Editor in:
    Anti-Cancer Agents in Medicinal Chemistry

    Dr. Mei Lin is a Professor of Medical Science, and holds a Doctor of Philosophy in Medicine. Her main research areas are nanomedicine, personalized diagnosis and therapy for cancer and tumor molecular imaging. Prof. Mei Lin is the academic leader of Jiangsu Key Clinical Specialty, the clinical laboratory of Taizhou People’s Hospital Affiliated to Nantong University. Prof. Mei Lin research work focuses on synthesis and characterization of nanodrug and molecular probe, tumor molecular imaging , drug delivery, targeted therapy for cancer including chemotherapy, gene-therapy, magnetic thermotherapy and nuclide therapy.

  • Generic placeholder image

    A.M. Al-Abd
    Gulf Medical University Ajman United Arab Emirates

    Executive Guest Editor in:
    Anti-Cancer Agents in Medicinal Chemistry

    Dr. Al-Abd has been promoted in the fields of research/academia from research assistant to associate research professor at the National Research Centre of Egypt. He worked for 6 years as an Assistant/Associate Professor at King Abdul-Aziz University and supervised the research activities within the Tissue Culture facility in the Faculty of Pharmacy, King Abdul-Aziz University. He is currently an Associate Professor of Pharmaceutical Sciences at the Gulf Medical University, United Arab Emirates. In addition to his title, he is a visiting scholar in Bouvé College of Health Sciences, Northeastern University, USA.

  • Generic placeholder image

    I.H. Eissa
    Al-Azhar University Cairo Egypt

    Executive Guest Editor in:
    Anti-Cancer Agents in Medicinal Chemistry

    Ibrahim Hassan Eissa received his B.Sc. in 2003, Master’s degree in Medicinal Chemistry in 2009 and a PhD degree in 2012, both from the Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Since 2017, he has been an Associate Professor of Medicinal Chemistry at the Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Al-Azhar University and was made a manager of QAU in 2018. His scientific activity is focused on design, molecular modelling studies and synthesis of new bioactive compounds with potential anticancer activity against EGFR, VEGFR-2, Topoisomerases, tubulins, Carbonic anhydrases, and thymidylate synthase.

Read More